DataArt Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023

DataArt, a global software engineering firm, was recognized in the Hype Cycle™ for Life Science Clinical Development, 2023 by Gartner, a company that delivers actionable, objective insight to executives and their teams. Gartner’s expert guidance and tools enable faster, smarter decisions and stronger performance on an organization’s mission-critical priorities.

According to the report:

• “This Hype Cycle explores innovative technologies that are specifically relevant to life science clinical development programs in the pharmaceutical, biotechnology, diagnostics, medical device, research institution and contract research sectors.”
• “Artificial intelligence (AI) in clinical development represents the use of the multiple AI disciplines to optimize aspects of trial activities. These include machine learning (ML), deep learning (DL), natural language processing (NLP), generative AI and AI-enabled advanced analytics. As AI use and expertise become more prevalent, Gartner expects AI to be ingrained in software development and part of a standard set of capabilities built into application development.”

Daniel Piekarz, SVP and Head of Healthcare & Life Sciences at DataArt said:

“It’s the third consecutive year that DataArt has been recognized as a Sample Vendor in AI in Clinical Development in the Gartner Hype Cycle report”.

“We consider it a remarkable accomplishment, demonstrating our extensive expertise in Healthcare and Life Sciences, and the real impact of our AI/ML Centers of Excellence. Moving ahead, we eagerly anticipate further assisting our clients in exploring the immense potential of AI/ML innovation to develop novel clinical therapies that will save lives. We have no doubt that AI/ML technologies, including Generative AI, will continue to revolutionize medicine, from Drug Discovery and Clinical Trial Matching to Clinical Decision Support.”

Max Zhdanov, VP of Analyst Relations added:

“I am very glad to see the tremendous, continued progress made by our Healthcare and AI/ML teams. I am proud that we are recognized in this report in the Artificial Intelligence for Clinical Development category for the third year in a row. We believe, this is a great testament to our capabilities in this domain,”.

For more information please visit gartner.com.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

GARTNER is a registered trademark and service mark, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

DataArt was recognized in the Hype Cycle^™ for Life Science Clinical Development, 2023 by Gartner^®